b12 Labs
Making hard molecules for Pharma and Biotech
San Francisco
3 employees
Healthcare
Pre-seed
About b12 Labs
Making hard molecules for Pharma and Biotech
Making hard molecules for Pharma and Biotech
Making hard molecules for Pharma and Biotech
Last stage
Pre-seed
Investors
Zlatko Jončev
at b-12 we are developing AI agents for automated workflows in chemistry and pharma R&D, as a way of manifestating chemical super intelligence in physical world. our long-term goal is to create autonomous labs that can perform complex, multistep syntheses with minimal human intervention.
Andres Bran
Built the first AI agent that can autonomously think and make molecules in a robotic lab, published in Nature Machine Intelligence (750+ citations), and won best paper at NeurIPS AI for Science. PhD at EPFL (AI+Chemistry), intern at Max Planck Institute.
LinkedIn
Zlatko Jončev
at b-12 we are developing AI agents for automated workflows in chemistry and pharma R&D, as a way of manifestating chemical super intelligence in physical world. our long-term goal is to create autonomous labs that can perform complex, multistep syntheses with minimal human intervention.
LinkedIn
Andres Bran
Before b-12, Andres built the first AI agent to plan and make molecules in a robotic lab (750+ cites in Nature Machine Intelligence, and Best Paper at NeurIPS AI for Science), along with several other works in agents and LLMs for chemistry (1100+ citations). He was an Intern at Max Planck (Math in Science), and PhD at EPFL (AI+Chemistry). Automation is the future of chemistry, but integration and human operability is the hidden demon nobody talks about. We're fixing that at b-12.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.